Senate Hemp Regulation Bill’s Broad Prohibition On Synthetics In Supplements Has Industry Attention

Provision in Wyden and Merkley’s “Cannabinoid Safety and Regulation Act” referencing FDA authority outside hemp-derived ingredients could provide agency with needed authority to force from the market products labeled as supplements but containing drugs or eliminate the use of many safe ingredients in supplements.

• Source: Shutterstock

Legislation recently introduced in the Senate has the dietary supplement industry’s attention for reasons other than proposing a solution to the Food and Drug Administration’s hemp conundrum more appealing than a House bill introduced earlier in the year.

The reason for their attention varies among industry

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Cannabis/CBD

More from Ingredients & Safety